North Shore/Long Island Jewish PRIME — Manhasset, New York

North Shore/Long Island Jewish PRIME is a clinical research site located in Manhasset, New York, United States.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

North Shore/Long Island Jewish PRIME has participated in 2 clinical trials.

Therapeutic areas: Hepatitis C Virus Infection.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for North Shore/Long Island Jewish PRIME?

North Shore/Long Island Jewish PRIME has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has North Shore/Long Island Jewish PRIME conducted?

North Shore/Long Island Jewish PRIME has 2 clinical trials on record. Their work covers Hepatitis C Virus Infection.

Is North Shore/Long Island Jewish PRIME accredited by Crixeo Health?

North Shore/Long Island Jewish PRIME has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about North Shore/Long Island Jewish PRIME?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.